CAS 519055-62-0 appears in our catalog under these names: Tasisulam, Tasisulam/ 99.97% (existing batch purity), Tasisulam, >95.0%(HPLC)(qNMR), Tasisulam 95%, N-((5-Bromothiophen-2-yl)sulfonyl)-2,4-dichlorobenzamide, 95%, 95%. Offered by: GLPBio, TargetMol, TCI, Ambeed, Chemat. Available pack sizes: 10mg, 10mM (in 1ml dmso), 50mg, 5mg, 25mg, 100mg, 200mg, 500mg.
Tasisulam is a thiophene substituted by a 2,4-dichlorobenzamide-N-sulfonyl and bromo groups at positions 2 and 4, respectively. It induces tumour cell apoptosis via ROS induction and mitochondrial membrane potential loss and currently in clinical development for the treatment of cancer. It has a role as an antineoplastic agent, an angiogenesis inhibitor and an apoptosis inducer. It is a dichlorobenzene, a member of thiophenes, an organobromine compound and a N-sulfonylcarboxamide.
Source: ChEBI
| Molecular formula | C11H6BrCl2NO3S2 |
|---|---|
| Molecular weight | 415.1 g/mol |
| IUPAC name | N-(5-bromothiophen-2-yl)sulfonyl-2,4-dichlorobenzamide |
| InChIKey | WWONFUQGBVOKOF-UHFFFAOYSA-N |
| SMILES | C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br |
Computed by PubChem (NCBI)